Pharmaceuticals all over the world are growing and the need for treatments and medicines are on the rise as we are not adopting healthy ways of life and causing more harm to our bodies and making more vulnerable to diseases.
The European Investment Bank and ISA Pharmaceuticals have signed a EUR 20 million loan agreement to support the development of ISA's therapy for cancers caused by the Human Papillomavirus type 16 (HPV16). The EI....
Tags : Pharmaceuticals, European Investment Bank and ISA Pharmaceuticals, Persistent HPV16 infection,
comments (0)